G
ene silencing mechanisms including RNA interference (RNAi), heterochromatin formation (1), and repeatinduced silencing (2) are associated with base-paired RNA structures. For example, double-stranded RNA (dsRNA) and hairpin RNA (hpRNA) can trigger RNAi to silence the expression of genes with matching sequence (3) . These homologydriven silencing mechanisms are thought to protect the organism against viruses (4) and mobile repetitive elements such as transposons (5, 6) . Consequently, these silencing mechanisms also reduce the expression of Caenorhabditis elegans transgenes that are present in multiple tandem copies (7) . In plants, transgenic expression or introduction of an RNAi trigger locally within a tissue can silence the target gene or virus throughout the organism (8, 9) . Similar systemic silencing can be triggered in some animals by ingestion, local introduction, or overexpression of RNAi triggers in some tissues (10, 11) . In contrast to experimentally introduced RNAi triggers, whether RNAi triggers associated with endogenous gene silencing mechanisms (e.g., transcribed dsRNAs) are similarly transported between cells is unknown.
Several studies have provided insight into the distinct mechanisms used by plants and animals to transport experimentally introduced RNAi triggers between cells. Plants transport RNAi triggers between adjacent cells through dynamic intercellular bridges called plasmodesmata and between distant cells via the phloem vascular tissue (12, 8) . In addition, genetic screens in plants have identified some of the proteins required for the generation or reception of transported silencing signals (13) . Genetic screens in the nematode C. elegans have identified a dsRNA channel called SID-1 as a key component required for the import of silencing signals into all cells sensitive to systemic RNAi (14) . It is not known whether SID-1 is required for export of silencing signals. Most animals, except some insects, have at least one SID-1 homolog. In mouse, the SID-1 homolog sidT1 is required for the import of lipid-modified siRNA into hepatocytes (15) , suggesting that the import of RNAi triggers through SID-1 is a broadly conserved process among animals. In cultured Drosophila S2 cells, which lack SID-1 homologs, import of RNAi triggers occurs through a slow and energy-dependent process (16, 17) . Expressing C. elegans SID-1 in these cells, however, enables rapid energy-independent dsRNA import (17) , suggesting that SID-1 functions as a dsRNA channel.
Here, we show that C. elegans requires SID-1 to efficiently reduce the expression of multicopy transgenes, suggesting that transgene silencing in one cell produces mobile silencing signals that function to initiate and/or maintain transgene silencing in another cell. Tissue-specific expression of either hpRNA or dsRNA in many tissues results in SID-1-dependent systemic silencing. We confirm that SID-1 is required for the import of these silencing signals, but show that tissues that lack SID-1 can export these silencing signals. Finally, when RNAi triggers are expressed in ingested Escherichia coli, silencing signals can be transported from the gut lumen to internal tissues via gut cells that lack SID-1. Therefore, we conclude that silencing signals are exported from C. elegans tissues through multiple SID-1-independent pathways.
Results
Efficient Transgene Silencing Requires SID-1. Transgene tandem arrays in C. elegans are subject to repeat-induced silencing that depends on genes required for RNAi and is more pronounced in mutants that show enhanced RNAi (e.g., eri-1, rrf-3) (18, 19) . Repeat-induced silencing often occurs in a mosaic manner such that only a subset of cells containing the transgene tandem array shows silencing of transgene expression. It is unknown whether the silencing triggers, likely derived from aberrant expression of dsRNA and hpRNA from the tandem arrays, remain in the nucleus or are transported to the cytoplasm or between cells. If such RNAi triggers are transported between cells, then the extent of repeat-induced silencing should depended on SID-1, a dsRNA channel required for systemic RNAi (14) .
To determine whether repeat-induced silencing spreads beyond the cells in which silencing is initiated we compared the extent of silencing in sid-1(ϩ) and sid-1(-) strains. To induce and monitor spontaneous transgene silencing we used a transgene, sur-5::gfp, which expresses nuclear-localized green fluorescent protein (GFP) in all somatic cells. sur-5::gfp expression is detected in all somatic cells in a wild-type genetic background (Fig. 1A) , whereas sur-5::gfp expression is silenced in many cells in an eri-1(-) background ( (19) and Fig. 1B ). This silencing is readily observed in the large nuclei of the gut cells ( Fig. 1 A, dashes vs. Fig. 1B, brackets) . In a wild-type background, 30.1 Ϯ 0.2 gut nuclei show bright GFP fluorescence, whereas in an eri-1(-) background, only 15.3 Ϯ 0.7 gut nuclei show bright GFP fluorescence (Fig. 1D ). Although sur-5::gfp expression was not detectably altered in a sid-1(-) background (data not shown), we found that in a sid-1(-); eri-1(-) double mutant background, 25.6 Ϯ 0.6 gut nuclei show bright GFP fluorescence (Figs. 1 Cand D) . This significant decrease in transgene silencing in the sid-1(-); eri-1(-) background compared with the eri-1(-) background (P Ͻ 0.001) shows that sid-1 is required for efficient repeat induced silencing and that, like RNAi, such silencing produces mobile silencing signals. Further, the significant transgene silencing seen in the sid-1(-); eri-1(-) double mutant background compared with that in the wild-type background (P Ͻ 0.001) likely reflects the extent of cell-autonomous transgene silencing. Thus, to efficiently silence transgene tandem arrays, C. elegans requires the transport of silencing signals derived from expressed transgenes between cells and/or tissues.
Because the source for repeat-induced silencing triggers, the sur-5::gfp transgene, is expressed in all tissues, the observed sid-1-dependent silencing may reflect transport of silencing signals between cells within a tissue or may also involve transport between tissues. To determine whether silencing signals generated within a single tissue are transported between cells within that tissue, we examined silencing of the muscle-specific myo-3::gfp transgene (supporting information (SI) Fig. S1 A) . We found that this transgene is silenced in an eri-1(-) background (brackets in Fig. S1B ), whereas sid-1(-); eri-1(-) animals appeared to have more body-wall muscle (bwm) cells that showed GFP fluorescence. To objectively compare the extent of silencing we measured the total GFP fluorescence per L4 animal for each genotype. This analysis showed that silencing is less efficient in the sid-1(-); eri-1(-) background than in the eri-1(-) background but more efficient than in the wild-type background (Fig. S1D) . These results indicate that repeat-induced silencing signals are transported between cells within a single tissue.
Transgenic Expression of Either hpRNA or dsRNA Causes Transport of
Silencing Between Multiple Tissues. Our analysis of transgene silencing suggests that silencing signals produced in the nucleus may be transported between cells; however, other studies have produced conflicting data. These studies examined systemic silencing from tissue-specific expression of either invertedrepeat DNA constructs to produce hpRNA or a mix of senseand antisense-oriented DNA constructs to produce dsRNA. For example, whereas the transport of RNAi from the pharynx to the bwm was detected when hpRNA was expressed in the pharynx (14) , transport of RNAi from bwm cells to other tissues was detected only under certain environmental conditions when hpRNA was expressed in the bwm (20) . Further, no transport of RNAi between cells was detected when hpRNA was expressed in the gut (21) . Finally, RNAi induced by cell-specific expression of dsRNA was restricted to the cells expressing the dsRNA (22) , suggesting that, in contrast to silencing triggered by transgenic expression of hpRNA, silencing triggered by transgenic expression of dsRNA may not be transported between cells. These observations suggest that the ability to export RNAi triggers may be restricted by cell type or RNA structure and may also be regulated by environmental conditions.
To directly compare systemic silencing triggered by dsRNA expression vs. by hpRNA expression, we expressed gfp-dsRNA in the pharynx, a tissue that shows readily detectable systemic silencing on gfp-hpRNA expression (14) . We coinjected DNA constructs that express sense and anti-sense gfp RNA under the control of the pharynx-specific myo-2 promoter ( Fig. 2A) into sid-1(ϩ) and sid-1(-) strains that express GFP in both the pharynx and the bwm. In sid-1(ϩ) animals GFP expression was silenced in both the pharynx and the bwm (Fig. 2B , brackets in Middle), but in sid-1(-) animals GFP expression was silenced only in the pharynx (Fig. 2B , bracket in Right). Thus, the nuclear expression of gfp-dsRNA results in the SID-1-dependent transport of RNAi from the pharynx to the bwm cells. To examine the silencing of endogenous genes, we introduced similar constructs that express sense and antisense fragments of the bwm-specific unc-22 gene in the pharynx. Animals that show unc-22 silencing are easily observed as they twitch in response to the paralyzing drug levamisole (3) . Expression of the unc-22 sense and antisense constructs in the pharynx resulted in animals that show SID-1-dependent Unc-22 twitching phenotypes (Fig. 2C) , demonstrating that expressed dsRNA produces a mobile silencing signal in the pharynx that can move to the bwm. These results and the results from Winston et al. (14) show that pharyngeal expression of either hpRNA or dsRNA can produce effective mobile silencing signals.
To determine whether nonpharyngeal cells can export silencing signals, we transformed animals that expressed nuclearlocalized GFP in all cells (Fig. 3 A and AЈ) with constructs that coexpressed both gfp-hpRNA and a red fluorescent protein, DsRed, in bwm cells or that coexpressed gfp-dsRNA, and DsRed in the gut. The resulting tandem arrays were not integrated into the genome and were thus mitotically unstable (23) We found that in addition to the silencing of GFP expression in the red gut and red bwm cells that express the RNAi trigger, silencing of GFP expression was also observed in nonred gut and nonred bwm cells, respectively (data not shown). Further, the muscleexpressed gfp-hpRNA and gut-expressed gfp-dsRNA constructs silenced GFP expression in cells of surrounding tissues ( Fig. 3 B and C). Consistent with systemic silencing, when these constructs were introduced into a sid-1(-) background, silencing was restricted to the cells that expressed the RNAi trigger ( Fig. 3 BЈ and CЈ). Similar results were obtained when gfp-dsRNA was expressed in the bwm (data not shown). These results show that the silencing in cells that do not express the RNAi trigger is because of SID-1-dependent transport of RNAi from the bwm cells or from gut cells. Thus, the ability to export silencing is not restricted to pharyngeal cells. Neurons perform RNAi inefficiently (3) and some neurons (e.g., GABA-ergic motor neurons) do not show detectable RNAi-mediated silencing in wild-type animals. To determine whether neurons can export a silencing signal, we introduced constructs that coexpress gfp-hpRNA and DsRed in neurons into a strain that expresses nuclear-localized GFP in all cells. We found that GFP expression is silenced in most neurons that express gfp-hpRNA ( Fig. 3 D and DЈ) , with the notable exception of the GABA-ergic motor neurons, which were not detectably silenced (data not shown). Although the nonred neurons continued to show bright GFP expression, there was robust silencing of GFP expression in all other tissues (Fig. 3D) . As expected for a transported silencing signal, silencing in nonred cells was not detectable in sid-1(-) animals (Fig. 3DЈ) . Thus, these results suggest that neurons, which perform RNAi inefficiently, can export silencing signals.
SID-1 Is Not Required for Export of RNAi Triggers.
Because sid-1 is not detectably expressed in neurons (14) , the ability of neurons to efficiently export silencing signals suggests that sid-1 may not be required for export. To determine whether SID-1 is required for the export of silencing signals, we generated mosaic sid-1(-) animals in which a tissue that lacks sid-1 expresses gfp-hpRNA (exporting tissue) and monitored the silencing of gfp in another tissue that expresses a rescuing sid-1(ϩ) cDNA (importing tissue). If sid-1 is not required for export then silencing will be observed in the sid-1(ϩ) importing tissue, whereas, if sid-1 is required for export, then silencing will not be observed in the importing tissue.
We first expressed gfp-hpRNA specifically in the pharynx of sid-1(-) animals that express gfp in the pharynx, gut, and bodywall muscle cells (Fig. 4A ). In these animals, GFP expression is detectably silenced only in the pharynx. To determine whether silencing signals derived from the RNAi trigger expressed in the sid-1(-) pharynx were exported, we expressed sid-1(ϩ) only in the gut of these animals. GFP expression was silenced specifically in the gut, whereas in the bwm cells, which were sid-1(-), GFP expression was not detectably silenced ( Fig. 4B) . Thus, silencing signals derived from the expression of gfp-hpRNA are exported from the pharynx independent of SID-1.
To control for the possibility that export from the pharynx may have occurred through SID-1 because of ectopic SID-1 expression in the pharynx, we examined the SID-1 dependence of silencing in multiple tissues. When we introduced constructs that express gfp-hpRNA in all neurons of sid-1(-) animals that express GFP in a subset of neurons and in bwm cells, no silencing of GFP expression was observed. However, subsequent introduction of constructs that express sid-1(ϩ) specifically in bwm cells resulted in robust silencing of GFP expression in bwm cells (Fig. S2) , consistent with SID-1-independent export of silencing signals from neurons to bwm. Similarly, silencing signals derived from RNAi triggers expressed in sid-1(-) pharynx silenced GFP expression in sid-1(ϩ) bwm cells (Fig. S2) , consistent with SID-1-independent export of silencing signals from pharynx to bwm cells. Taken together, the data suggest that silencing signals derived from expressed RNAi triggers can be exported from tissues independent of SID-1.
Ingested RNAi Triggers Are Transported Across Gut Cells Independent of SID-1. A common method to deliver RNAi triggers to C. elegans is to feed them E. coli that expresses dsRNA or hpRNA. Ingestion of the RNAi trigger results in systemic silencing of the target gene in most tissues (24) . Silencing in gut cells by ingested RNAi triggers requires SID-1 and SID-2, a transmembrane protein found almost exclusively on the gut luminal membrane (25) . How the ingested RNAi triggers or a silencing signal derived from such triggers are delivered into the gut or transported from the gut to other internal tissues is unknown. To determine whether SID-1 is required in the gut for the transport of silencing signals from the lumen to internal tissues during feeding RNAi, we generated sid-1(-) mosaic animals where wild-type SID-1 was expressed only in bwm cells and examined silencing of bwm-expressed genes in response to feeding RNAi. If SID-1 is not required in the gut for ingested silencing signals to pass through the gut cells to silence genes in the bwm, then the RNAi trigger is likely transported from the gut lumen to the bwm cells without entry into the cytoplasm of gut cells. If SID-1 is required in the gut for ingested silencing signals to silence genes in the bwm, then the RNAi triggers likely enter the cytoplasm of gut cells before subsequent transport to the bwm cells.
To induce feeding RNAi of genes in the bwm, we used E. coli that express gfp-hpRNA with an unc-22 loop, which triggers the silencing of both gfp and unc-22 likely because of the production of unc-22 dsRNA in the E. coli (14) . When wild-type animals that express nuclear-localized GFP in all somatic cells (sur-5::gfp) were fed E. coli that express gfp-hpRNA with an unc-22 loop, GFP expression was efficiently silenced in all nonneuronal cells (Fig. 5A, Left) . This silencing was abolished in sid-1(-) animals. However, when a construct that expresses sid-1(ϩ) in the bwm and a construct that expresses DsRed in the bwm were coinjected into these sid-1(-) animals, the resultant red sid-1(ϩ) bwm cells were silenced in response to feeding RNAi (Fig. 5A , compare Middle and Right images). Consistent with a lack of ectopic SID-1 expression in the gut, GFP expression was not detectably silenced in the gut cells of sid-1(-) animals that express sid-1(ϩ) in bwm cells. Thus, the ingested gfp-hpRNA is transported from the lumen of a sid-1(-) gut to sid-1(ϩ) bwm. We then examined unc-22 silencing in the above strains. Silencing unc-22 results in animals that respond to the drug levamisole by twitching, and in a wild-type background, 100% of the animals twitched when fed E. coli that express gfp-hpRNA with an unc-22 loop (Fig. 5B) . This twitching was abolished in sid-1(-) animals (Fig. 5B , 0% twitching) but was rescued when sid-1(ϩ) was expressed only in the bwm of sid-1(-) animals (Fig. 5B, 100%  twitching) . Thus, the ingested gfp-hpRNA with unc-22 loop and unc-22 dsRNA were exported from a sid-1(-) gut to silence unc-22 in the sid-1(ϩ) bwm. These results suggest that ingested RNAi triggers can be transported from the gut lumen into the animal independent of SID-1. To control for undetected misexpression of SID-1 in gut cells from the bwm-specific promoter, we isolated sid-1 genetic mosaics by mitotic segregation of a transgene array that expresses GFP in all cell types and that expresses sid-1 from its native promoter, which is active in all nonneuronal cells. Rare mosaic animals that had lost the array in all gut cells, as monitored by lack of gut GFP expression, but still expressed GFP in bwm and/or hypodermal cells were identified and placed as L4 larvae on E. coli that express gfp-hpRNA. Consistent with the analysis using tissue-specific promoters, compared with control animals, we observed modest silencing of GFP expression (8/8 animals). Therefore, during feeding RNAi, ingested RNAi triggers can be transported from the gut lumen to cells in other tissues without entry into the cytoplasm of gut cells.
Discussion
We found that SID-1-dependent mobile silencing signals contribute to transgene silencing in C. elegans. In addition, cells of all tested tissue types can export silencing signals derived from expressed RNAi triggers. Finally, we found that C. elegans cells can use SID-1-independent pathway(s) to export silencing signals upon transgenic expression of or ingestion of RNAi triggers.
Export of RNA Silencing from Cells That Express RNAi Triggers. Import of RNAi triggers into cells is readily observed in many organisms upon injection of dsRNA into the body cavity (11) . For example, in adult Drosophila, intraabdominal injection of dsRNA can silence target genes in the central nervous system (26) . In C. elegans, injection of dsRNA into the pseudocoelomic body cavity can cause silencing of target genes in most tissues (3) For example, in the C. elegans gut and in Drosophila, silencing by transgenic expression of hpRNAs was apparently restricted to cells that express the RNAi trigger (21, 27) . However, we found that expression of RNAi triggers in the cells of most C. elegans tissues, including gut cells and neurons, results in systemic silencing. Therefore, we propose that a mechanism to export silencing signals derived from expressed RNAi triggers exists in most tissues but may be active to different extents in different tissues.
SID-1-Independent Export.
Although C. elegans tissues require SID-1 to import silencing signals, we found that they do not require SID-1 to export silencing signals (Fig. 4 and Fig. S2 ). Exported silencing signals may be produced in the nucleus or in the cytoplasm. Recent reports show that RNAi that occurs in the nucleus uses effector proteins distinct from those used in the cytoplasm (28) , and similar specialized protein machinery may generate the transported silencing signal in either the nucleus or cytoplasm. Intriguingly, many of the mRNAs and microRNAs that are transported in vesicles between cultured mammalian mast cells are not found in the cytoplasm of the exporting cell, consistent with a nuclear origin for these transported RNAs (29 of silencing signals to curtail the spread of the infection. In support of this possibility, virulence factors of some plant viruses specifically inhibit the transport of silencing signals between cells (4). However, evaluation of this hypothesis in C. elegans awaits the identification of a virus that infects C. elegans in nature.
Transcytosis of Ingested RNAi Triggers?
In addition to the transport of silencing signals between cells within an organism, robust uptake of RNAi triggers from the environment into the organism is readily observed in some animals (10) . For example, ingestion of E. coli that expresses RNAi triggers results in systemic silencing of the target gene in most tissues in C. elegans and in planaria. However, how silencing signals are exported to internal tissues from the gut lumen is unknown. We found that ingested RNAi triggers apparently do not require SID-1 to pass through the C. elegans intestine to silence target genes in sid1(ϩ) tissues that are not exposed to the environment (Fig. 5) . SID-1 independent transport of RNAi triggers across the gut was more obvious in sid-1(-) animals where SID-1 was overexpressed in the body-wall muscles (bwm) by using a bwm-specific promoter than in sid-1(-) mosaic animals where SID-1 was expressed under its own promoter in nongut tissues. The difference in the level of silencing observed in the 2 experiments may reflect undetected SID-1 misexpressed in the gut or differences in SID-1 expression levels in target tissues. Knockdown of some vesicle transport proteins in C. elegans results in resistance to feeding RNAi (16) , suggesting that ingested RNAi triggers are taken up into vesicles. A parsimonious model that explains the SID-1-independent import of ingested RNAi triggers is transcytosis (31) of the ingested RNAi triggers across the gut. Specifically, we propose that ingested RNAi triggers are endocytosed into vesicles that bud off from the gut lumen, and that these vesicles then release their cargo into the pseudocoelomic cavity by fusing to the basal membrane of the gut. Because most tissues in C. elegans are exposed to the pseudocoelomic cavity, the ingested RNAi triggers can then be taken up through SID-1 into most tissues resulting in systemic silencing throughout the animal.
Materials and Methods
All C. elegans strains were generated and maintained using standard methods (32) . Transgenic animals were generated by injecting DNA in 10 mM Tris-Cl pH 8.5 into the germ line by using standard methods (23) , and at least 3 independent transgenic lines were analyzed for each experiment. Representative L4 or adult animals were imaged by using exposure times that avoid saturation of pixels by the brightest cells on an Axiovert 200 microscope (Zeiss) and all images within a figure were adjusted in the same way by using Photoshop (Adobe) for display and to enable comparison. Feeding RNAi and unc-22 silencing measurements were adapted from standard procedures (33) . By using Wilson's estimates and the proportion of pooled values, 95% confidence intervals for a single proportion and P values for comparison of two proportions were calculated, respectively (34) . Detailed procedures are provided in the SI Materials and Methods, and a list of primers used to generate PCR fragments is available in Table S1 . HC565 ccIs4251; mIs11; sid-1(qt9), HC566 nrIs20; sid-1(qt9), HC567 nrIs20; eri-1(mg366), HC568 nrIs20; eri-1(mg366) Transgenes. In all cases except one (see below), transgenic animals were healthy and appeared morphologically normal.
Plasmids: pRF4 (23) or pHC183 (14) were used to obtain transgenic animals that roll or that express DsRed in the body-wall muscles (bwm), respectively.
To express gfp-hpRNA in the bwm: A 1:1 mix (0.035 mg/ml each) of pHC172 (14), which has the gfp coding region as an inverted repeat sequence under the control of the myo-3 promoter, and pHC183 was injected into HC195 or HC566 animals to generate transgenic lines.
To express gfp-hpRNA in all neurons: The inverted-repeat sequence targeting gfp was subcloned from pHC172 under the control of the Ϸ3.4 kb promoter of the pan-neuronally expressed gene F25B3.3 (S1) to generate pHC337. A mix of pHC337 (0.04 mg/ml) and the coinjection marker PF25B3.3::DsRed (0.008 mg/ml) was injected into HC195 and HC566 animals to generate transgenic lines. A 1:1 mix of pHC337 and pRF4 (0.04 mg/ml each) was injected into HC573 animals to generate transgenic lines and a representative rolling transgenic line was designated as HC570.
To express sid-1(ϩ) cDNA in the bwm: The SID-1 cDNA with a C-terminal FLAG tag was cloned as an NheI/KpnI fragment under the control of the myo-3 promoter in pPD96.52 (gift of Andrew Fire, Stanford University) to generate pHC355. A 1:1 mix of pHC355 and pHC183 (0.04 mg/ml each) was injected into HC114, HC573, or rolling HC570 animals to generate transgenic lines. Some double transgenic animals produced by injecting rolling HC570 animals showed growth and morphological defects.
PCR fusion products: Promoter sequences were amplified with Expand Long Template (ELT) polymerase (Roche) and either noncoding sequences or coding sequences along with 3ЈUTR were amplified with PfuUltra II Fusion polymerase (Stratagene) by using primers that generate Ϸ50 bp overlap between the two PCR fragments. The fusion products were generated with ELT polymerase by using the amplified promoter and the coding sequences as template and nested primers. In some cases, the two PCR fragments were fused in vivo). The specific templates and primers used to generate the various PCR fusion products are detailed below. The sequences of all primers used (P1-P41) are provided in Table S1 .
To make the coinjection marker Pmyo-2::DsRed: The myo-2 promoter was amplified from pHC168 (14) with primers P1 and P3. The DsRed2 cDNA along with unc-54 3ЈUTR was amplified from pHC183 (14) with primers P4 and P5. The fusion product was generated with primers P2 and P6. Transgenic animals generated using this marker showed bright DsRed2 fluorescence in pharyngeal muscles and sometimes showed faint fluorescence in bwm, likely because of trace expression of pHC183, the template used to amplify DsRed cDNA.
To make the coinjection marker Psid-2::DsRed: The sid-2 promoter was amplified from wild-type genomic DNA (gDNA) with primers P23 and P25. The DsRed2 cDNA along with unc-54 3ЈUTR was amplified from pHC183 with primers P26 and P5. The two PCR products were mixed at 1:1 ratio (0.008 mg/ml each) for injection into animals to generate transgenic lines where the PCR products would be fused in vivo.
To make the coinjection marker PF25B3.3::DsRed: The F25B3.3 promoter was amplified from gDNA with primers P39 and P40; and DsRed2 cDNA along with unc-54 3ЈUTR was amplified from pHC183 with primers P41 and P5. The two PCR products were mixed at 1:1 ratio (0.008 mg/ml each) for injection into animals to generate transgenic lines where the PCR products would be fused in vivo.
To express gfp-dsRNA in the pharynx: (a) Pmyo-2::gfp-sense: The myo-2 promoter was amplified from gDNA with primers P1 and P7. gfp coding sequence was amplified from pHC168 (14) with primers P8 and P9. The fusion was generated with primers P2 and P10. (b) Pmyo-2::gfp-antisense: The myo-2 promoter was similarly amplified with primers P1 and P12 and gfp coding sequence was similarly amplified with primers P11 and P13. The fusion product was generated with primers B2 and P14. A 1:1 mix of Pmyo-2::gfp-sense and Pmyo-2::gfp-antisense (0.025 mg/ml each) along with Pmyo-2::DsRed (0.008 mg/ml) was injected into HC46 or HC565 animals to generate transgenic lines.
To express unc-22-dsRNA in the pharynx: (a) Pmyo-2::unc22sense: The myo-2 promoter was amplified from pHC168 with primers P1 and P15. 589 bp of unc-22 coding sequence was amplified from gDNA with primers P16 and P17. The fusion product was generated with primers P2 and P18. (b) Pmyo-2::unc-22antisense: The myo-2 promoter region was similarly amplified with primers P1 and P20; and the 589 bp of unc-22 coding sequence was similarly amplified with primers P19 and P21. The fusion product was generated with primers C2 and P22. A 1:1 mix of Pmyo-2::unc-22sense and Pmyo-2::unc22antisense (0.024 mg/ml each) along with Pmyo-2::DsRed (0.008 mg/ml) was injected into N2 or HC196 animals to generate transgenic lines.
To express gfp-dsRNA in the gut: (a) Psid-2::gfp-sense: The sid-2 promoter was amplified from gDNA with primers P23 and P27. gfp coding sequence was amplified from pHC168 with primers P28 and P9. The fusion product was generated with primers P24 and P10. (b) Psid-2::gfp-antisense: The sid-2 promoter region was similarly amplified with primers P23 and P30 and gfp coding sequence was similarly amplified with primers P29 and P13. The fusion product was generated with primers E2 and P14. A 1:1 mix of Psid-2::gfp-sense and Psid-2::gfp-antisense (0.025 mg/ml each) along with Psid-2::DsRed (0.008 mg/ml) was injected into HC195 or HC566 animals to generate transgenic lines.
To express gfp-dsRNA in the bwm: (a) Pmyo-2::gfp-sense: The myo-3 promoter was amplified from gDNA with primers P31 and P33. gfp coding sequence was amplified from pHC168 with primers P34 and P9. The fusion product was generated with primers P32 and P10. (b) Pmyo-3::gfp-antisense: The myo-3 promoter region was similarly amplified with primers P31 and P36 and gfp coding sequence was similarly amplified with primers P35 and P13. The fusion product was generated with primers P32 and P14. A 1:1 mix of Pmyo-3::gfp-sense and Pmyo-3::gfp-antisense (0.034 mg/ml each) along with pHC183 (0.034 mg/ml) was injected into HC195 animals to generate transgenic lines.
To express sid-1(ϩ) cDNA in the gut: The sid-2 promoter was amplified from gDNA with primers P23 and P37; and sid-1(ϩ) cDNA along with unc-54 3ЈUTR was amplified from pHC355 with primers P38 and P5. A 1:1 mix of the two PCR products (0.008 mg/ml each) along with Psid-1::DsRed (0.008 mg/ml) was injected into HC575 to generate transgenic lines where the sid-2 promoter is fused to sid-1(ϩ) cDNA in vivo.
Microscopy. For Fig. 1D , similar distributions were obtained when the number of brightly fluorescent gut nuclei per worm was counted independently by two researchers (data not shown). For  Fig. 3, 30 transgenic animals from each of three transgenic lines (total of 90 animals) were analyzed per genotype. Animals were scored as showing silencing of GFP expression in nonred tissues if GFP expression was detectably dimmer than in control animals when scored at a fixed magnification. For Fig. S1 , 37 confocal slices that encompass the entire worm were collected using exposure times that avoid saturation of pixels by the brightest cells on an Axiovert 200 microscope (Zeiss) and the total fluorescence was measured by using Image J (National Institutes of Health). A maximum of three L4 worms were analyzed per slide and 10 animals were analyzed per genotype. The background fluorescence for each slide was calculated as the total fluorescence in 37 slices in a region where there were no worms. Background fluorescence of the slide was subtracted from the total fluorescence for each worm to obtain its average total fluorescence plotted in Fig. S1D .
Feeding RNAi. L1-L2 staged animals were fed E. coli that express gfp-hpRNA with an unc-22 loop (pPD126.25). The animals were grown at 20°C and were assayed 4 days later for GFP expression and unc-22 silencing. E. coli that do not express any hpRNA or dsRNA was used as control. Among animals that express GFP and that were Ͼ3 days past L2, Ϸ30%-60% showed reduced GFP fluorescence in the gut even when fed control OP50 E. coli.
Unc-22 Silencing. For Fig. 2 , Starved animals were transferred via an agar chunk to a plate with OP50 E. coli and 1.5 days later, young adults were assayed. Transgenic or control animals that twitch in response to 1 l of 3 mM Levamisole (in water) within 10 seconds were scored as twitching. Sixty animals per genotype or 20 animals for each of 3 independent transgenic lines (total 60) were scored. P1  CGAGGCATTTGAATTGGGGG  P2  GGTGGTGGACAGTAACTGTC  P3  CGTTCTCGGAGGAGGCCATCCGAATCGATAGGATCTCGG  P4  CCGAGATCCTATCGATTCGGATGGCCTCCTCCGAGAACG  P5  CGGTCATAAACTGAAACGTAAC  P6  CCTTATCATATGTTACGTTTCAG  P7  GAAAAGTTCTTCTCCTTTACTCATCCGAATCGATAGGATCTCGG  P8  CCGAGATCCTATCGATTCGGATGAGTAAAGGAGAAGAACTTTTC  P9  TTCATCCATGCCATGTGTAATC  P10  GTAATCCCAGCAGCTGTTAC  P11  CCGAGATCCTATCGATTCGGTTCATCCATGCCATGTGTAATC  P12  GATTACACATGGCATGGATGAACCGAATCGATAGGATCTCGG  P13  ATGAGTAAAGGAGAAGAACTTTTC  P14  GAAGAACTTTTCACTGGAGTTG  P15  CAATGTTGCCAAATCACTTTCGCCGAATCGATAGGATCTCGG  P16  CCGAGATCCTATCGATTCGGCGAAAGTGATTTGGCAACATTG  P17  CTTGATTTGGAATGGAACCTTC  P18  GGAACCTTCACAACACATGG  P19  CCGAGATCCTATCGATTCGGCTTGATTTGGAATGGAACCTTC  P20  GAAGGTTCCATTCCAAATCAAGCCGAATCGATAGGATCTCGG  P21  CGAAAGTGATTTGGCAACATTG  P22  GGCAACATTGGAGACTGATG  P23  CTGCCTATTGGGACTCAACG  P24  CAACGGGCGAGGAATCTTC  P25  CGTTCTCGGAGGAGGCCATTTCCTGAAAATATCAGGGTTTTG  P26  CAAAACCCTGATATTTTCAGGAAATGGCCTCCTCCGAGAACG  P27  GAAAAGTTCTTCTCCTTTACTCATTTCCTGAAAATATCAGGGTTTTG  P28  CAAAACCCTGATATTTTCAGGAAATGAGTAAAGGAGAAGAACTTTTC  P29  CAAAACCCTGATATTTTCAGGAATTCATCCATGCCATGTGTAATC  P30  GATTACACATGGCATGGATGAATTCCTGAAAATATCAGGGTTTTG  P31  GGTCGGCTATAATAAGTTCTTG  P32  CCCGACAAAACATGAGTATTTC  P33  GAAAAGTTCTTCTCCTTTACTCATCAAGGGTCCTCCTGAAAATG  P34  CATTTTCAGGAGGACCCTTGATGAGTAAAGGAGAAGAACTTTTC  P35  CATTTTCAGGAGGACCCTTGTTCATCCATGCCATGTGTAATC  P36  GATTACACATGGCATGGATGAACAAGGGTCCTCCTGAAAATG  P37  AAATTATCAAATAAACACGAATCATTTCCTGAAAATATCAGGGTTTTG  P38  CAAAACCCTGATATTTTCAGGAAATGATTCGTGTTTATTTGATAATTT  P39  CGATAATCTCGTGACACTCG  P40  CGTTCTCGGAGGAGGCCATCGTCGTCGTCGTCGATGC  P41 GCATCGACGACGACGACGATGGCCTCCTCCGAGAACG
